Atlas Trials

Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients

Clinical trial NCT01579253 · UNKNOWN

Trial details

NCT number
NCT01579253
Sponsor
Ludwig-Maximilians - University of Munich
Status
UNKNOWN
Study type
OBSERVATIONAL
GlioblastomaNervous System NeoplasmsCentral Nervous System NeoplasmsAstrocytomaGliomaNeoplasms, NeuroepithelialNeuroectodermal TumorsNeoplasms by Histologic TypeNeoplasms, Nerve Tissue
Start date
2012-04-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.